Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, parallel group, multicenter pilot study evaluating the
efficacy and safety of alternative dosing of ribavirin vs. standard of care dosing in
combination with peginterferon alpha-2a in interferon naïve patients with chronic hepatitis c
genotype 1 infection.